The U.S. economy grew 2.5% last year, slower than in 2023 but still at a solid pace thanks to strong spending by American consumers buoyed by low unemployment. ECB Cuts Rates With Economy at a ...

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

NextEra Energy (NYSE:NEE – Get Free Report) had its target price upped by research analysts at BMO Capital Markets from $82.00 to $84.00 in a research report issued to clients and investors on Monday.

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...

We recently compiled a list of the 12 Safest Stocks to Buy According to Hedge Funds. In this article, we are going to take a ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...